eladocagene exuparvovec

Italy

Drugs containing this active substance

  • UPSTAZA

    Upstaza is used for the treatment of patients aged 18 months and older presenting with aromatic L-amino acid decarboxylase (AADC) deficiency, a hereditary condition that can affect nervous system development, movement, feeding, breathing, speech, and mental abilities.

    Form: solution for infusion

    Active substance Dosage
    eladocagene exuparvovec -

    ATC: A16AB26

    Manufacturer: PTC THERAPEUTICS INTERNATIONAL LIMITED